Amplifi Vascular Gains FDA Breakthrough Device Status & CMS Category B

A Breakthrough in Dialysis Access ST. LOUIS, Jan. 13, 2026 /PRNewswire/ -- Amplifi Vascular, Inc., has been granted Breakthrough Device Designation and Category B assignment from the Centers for Medicare & Medicaid Services (CMS) for the Amplifi Vein Dilation System. This significant...